Aug. 2, 2012 -- An experimental spray-on skin product may help people with chronic leg wounds heal faster and more effectively than available treatments, a new study suggests. People in the study ...

In the spray that they created – which is intended to be applied directly to open wounds – the peptide molecules are attached to specially structured microparticles of hydrogel.

Aug. 2, 2012 -- An experimental spray-on skin product may help people with chronic leg wounds heal faster and more effectively than available treatments, a new study suggests.

The global wound healing market is expected to hit $35 billion by 2025, according to a report by Transparency Market Research. [Photo: Nanomedic Technologies Ltd.] ...

Wayne Grube Jr., CEO of BC3 Technologies, joins Jenyne Donaldson to talk about the company's new SEAL Hemostatic Wound Spray which limits blood loss in critical injuries. Watch to hear how some ...

Kane will introduce its unique spray gel at the Boswick Burn and Wound Care SymposiumWINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company ...

An operation performed in January 2018 in Western France. A woman lost 1/3 of her skin due to flesh-eating bacteria and her wounds were healed with an experimental spray.

FOX45 Morning News gets a close look at BC3 Technologies' wound spray that is helping save lives around the world. Wed, 04 Jun 2025 23:29:55 GMT (1749079795588) Story Infinite Scroll ...

WMAR Baltimore, MD. SEAL hemostatic wound spray, made in Baltimore, the first of its kind on the market. Posted: May 29, 2025 | Last updated: June 6, 2025 ...

The U.S. Patent and Trademark Office issued BC3 Technologies, Inc. patent US12,263,185 for its hemostatic material and spray method of treating a bleeding wound of a human or an animal.

WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its ...